Cancer Immunotherapy: Diverse Approaches and Obstacles

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Malignant cells employ diverse strategies to evade immune detection and elimination.
• Understanding immune evasion is crucial for developing effective cancer immunotherapies.
• Cytokines, antibodies, and gene editing tools offer potential therapeutic avenues.

Purpose of the Study:

• To review the impacts of various cancer immunotherapy approaches.
• To explore the potential roles of these therapies in current and future cancer treatment.
• To highlight the significance of interdisciplinary collaboration in advancing cancer therapy.

Main Methods:

• Comprehensive literature review of cancer immunotherapy strategies.
• Analysis of immune evasion mechanisms employed by malignant cells.
• Evaluation of the roles of cytokines, monoclonal antibodies, adoptive cell therapy, immune checkpoint blockade, cancer vaccines, and CRISPR/CAS9.

Main Results:

• Cancer immunotherapy has advanced significantly due to improved understanding of tumor immune evasion.
• Various strategies, including cytokines (IL-2, IL-12, IL-15, IFN-α, TNF-α, TGF-β), monoclonal antibodies, adoptive cell therapy, immune checkpoint blockade, cancer vaccines, and CRISPR/CAS9, are key components.
• These approaches differ in efficacy and adverse effects based on cancer type, stage, and grade.

Conclusions:

• Cancer immunotherapy offers promising treatment avenues by targeting tumor immune evasion.
• The integration of basic science and translational experience is essential for overcoming challenges in treating highly malignant cancers.
• Continued research into novel immunotherapy strategies and combination therapies is critical for future progress.